LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy

被引:12
|
作者
Egranov, Sergey D. [1 ]
Hu, Qingsong [1 ]
Lin, Chunru [1 ,2 ]
Yang, Liuqing [1 ,2 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Long noncoding RNA; antigen presentation; tumour intrinsic factor; Cancer immunology; LONG NONCODING RNA;
D O I
10.1080/15476286.2020.1767455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long noncoding RNAs (lncRNAs) have been found to associate with all major types of malignancies and play important roles in regulating several hallmarks of cancer by interacting with proteins, DNA, and RNA. The possible functions of lncRNAs and their roles in the regulation of tumour growth will be reported and discussed in the present review. In our recent report, based on genetic mice models and a series of systematic analyses, we suggested that lncRNAs also play critical roles in the regulation of antigen presentation in tumour cells and allow tumour cells to escape immune surveillance, which further broadens the scope of understanding lncRNA functions and how they relate to cancer immunotherapy resistance.
引用
收藏
页码:1625 / 1627
页数:3
相关论文
共 50 条
  • [31] LncRNAs in Immune and Stromal Cells Remodel Phenotype of Cancer Cell and Tumor Microenvironment
    Li, Wenbin
    Zhang, Haohan
    You, Zuo
    Guo, Baozhu
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3173 - 3185
  • [32] Antigen presenting cell/tumor cell fusion vaccines for cancer immunotherapy
    Browning, Michael J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (07) : 1545 - 1548
  • [33] Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy
    Hatfield, Paul
    Merrick, Alison E.
    West, Emma
    O'Donnell, Dearbhaile
    Selby, Peter
    Vile, Richard
    Melcher, Alan A.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (07) : 620 - 632
  • [34] Acquired and intrinsic resistance in cancer immunotherapy
    Kelderman, Sander
    Schumacher, Ton N. M.
    Haanen, John B. A. G.
    MOLECULAR ONCOLOGY, 2014, 8 (06) : 1132 - 1139
  • [35] miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
    Di Martino, Maria Teresa
    Riillo, Caterina
    Scionti, Francesca
    Grillone, Katia
    Polera, Nicoletta
    Caracciolo, Daniele
    Arbitrio, Mariamena
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    CANCERS, 2021, 13 (07)
  • [36] Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy
    Xiao, Ying
    Dong, Yipeng
    Yu, Tiannan
    Wang, Rujie
    Gao, Yang
    Li, Song
    Nong, Shaojun
    Li, Wenguang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] LncRNAs and regulated cell death in tumor cells
    Wu, Yingying
    Wen, Xiaoling
    Xia, Yufang
    Yu, Xiao
    Lou, Yanhui
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Intrinsic signalling factors associated with cancer cell-cell fusion
    Thomas Dittmar
    Ralf Hass
    Cell Communication and Signaling, 21
  • [39] Tumor-cell-intrinsic transcriptional and epigenetic regulation of EGFR underlies the heterogeneity of immune infiltration and response to immunotherapy in pancreatic cancer
    Li, Jinyang
    Yuan, Salina
    Norgard, Robert
    Yan, Fangxue
    Blanco, Andres
    Stanger, Ben
    CANCER RESEARCH, 2021, 81 (05)
  • [40] Intrinsic signalling factors associated with cancer cell-cell fusion
    Dittmar, Thomas
    Hass, Ralf
    CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)